Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $489,977 | 168 | 80.4% |
| Travel and Lodging | $84,016 | 298 | 13.8% |
| Food and Beverage | $20,103 | 421 | 3.3% |
| Consulting Fee | $9,760 | 3 | 1.6% |
| Honoraria | $5,328 | 6 | 0.9% |
| Education | $130.83 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $444,067 | 535 | $0 (2021) |
| Novo Nordisk Inc | $117,353 | 166 | $0 (2024) |
| ABBVIE INC. | $39,362 | 87 | $0 (2024) |
| Horizon Therapeutics plc | $6,751 | 54 | $0 (2023) |
| Amgen Inc. | $922.33 | 21 | $0 (2024) |
| Lilly USA, LLC | $234.37 | 10 | $0 (2022) |
| IBSA Pharma Inc. | $187.01 | 11 | $0 (2024) |
| Valeritas, Inc. | $138.69 | 1 | $0 (2019) |
| Akrimax Pharmaceuticals, LLC | $70.91 | 3 | $0 (2017) |
| Tempus AI, Inc | $50.12 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $555.28 | 22 | Amgen Inc. ($333.43) |
| 2023 | $911.33 | 22 | Horizon Therapeutics plc ($765.05) |
| 2022 | $12,532 | 35 | Novo Nordisk Inc ($12,145) |
| 2021 | $12,156 | 39 | Novo Nordisk Inc ($9,671) |
| 2020 | $46,320 | 88 | AstraZeneca Pharmaceuticals LP ($24,418) |
| 2019 | $149,402 | 205 | AstraZeneca Pharmaceuticals LP ($94,228) |
| 2018 | $178,045 | 221 | AstraZeneca Pharmaceuticals LP ($157,132) |
| 2017 | $209,393 | 270 | AstraZeneca Pharmaceuticals LP ($168,241) |
All Payment Transactions
902 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/18/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/12/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $24.53 | General |
| 11/11/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $20.86 | General |
| 10/28/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/07/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $18.90 | General |
| Category: Endocrinology | ||||||
| 10/02/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $25.59 | General |
| 09/24/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/12/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $27.67 | General |
| Category: Endocrinology | ||||||
| 07/10/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: IMMUNOLOGY | ||||||
| 05/28/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $122.14 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/29/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: IMMUNOLOGY | ||||||
| 04/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $3.24 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Obesity | ||||||
| 03/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/12/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $17.22 | General |
| Category: Endocrinology | ||||||
| 01/30/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/29/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Honoraria | Cash or cash equivalent | $350.00 | General |
| Category: TEPEZZA | ||||||
| 12/18/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT | Food and Beverage | Cash or cash equivalent | $16.25 | General |
| Category: non-opioid analgesic | ||||||
| 11/06/2023 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: IMMUNOLOGY | ||||||
About Dr. Kathleen Hands, M.D
Dr. Kathleen Hands, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174558159.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kathleen Hands, M.D has received a total of $609,314 in payments from pharmaceutical and medical device companies, with $555.28 received in 2024. These payments were reported across 902 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($489,977).
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location San Antonio, TX
- Active Since 07/11/2006
- Last Updated 10/07/2010
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1174558159
Products in Payments
- FARXIGA (Drug) $296,897
- BYDUREON (Drug) $146,931
- Saxenda (Drug) $108,081
- Synthroid (Drug) $33,944
- Wegovy (Drug) $8,697
- TEPEZZA (Drug) $6,601
- SYNTHROID (Drug) $2,084
- EVENITY (Biological) $497.34
- Ozempic (Drug) $391.31
- TEPEZZA (Biological) $333.43
- Tirosint (Drug) $219.32
- V-GO (Device) $138.69
- ONGLYZA (Drug) $126.10
- HUMULIN (Drug) $123.58
- Prolia (Biological) $77.38
- Androgel (Drug) $64.28
- HUMALOG (Drug) $61.56
- SOLIQUA (Drug) $39.21
- Crysvita (Drug) $37.14
- LICART (Drug) $32.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in San Antonio
Eugenio Cersosimo, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1.3M
Ralph Defronzo, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1.3M
Firas Akhrass, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $868,751
Dr. Jeannie Baquero, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $668,321
Carolina Solis-Herrera, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $481,511
William Trigoso, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $231,800